| Rank (Similarity) |
PMID (PMCID) |
|
|---|---|---|
| 1 (4.0%) |
30952760 |
A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma. Miyata T, Beppu T, Imamura YU, Hayashi H, Imai K, Chikamoto A, Yamashita YI, Fukubayashi K, Ishiko T, Baba H. Anticancer Res. 2019;39(4):2139-2144. |
| Cirrhosis | ||
| Antineoplastic Combined Chemotherapy Protocols Bile Duct Neoplasms Cholangiocarcinoma Disease-Free Survival Females Gamma Rays Hepatectomy Homo sapiens Middle Aged | ||
| 1 (4.0%) |
30672653 |
Combined hepatocellular-cholangiocarcinoma with angiosarcomatoid change: A case report with immunohistochemical study. Hakozaki M, Ito S, Fujii T, Kiya Y, Udagawa H, Fukayama M, Fukusato T. Pathol Int. 2019;69(2):110-116. |
| Carcinoma | ||
| PECAM1 TP53 | ||
| Bile Duct Neoplasms Biomarkers, Tumor Cholangiocarcinoma Fatal Outcome Hemangiosarcoma Homo sapiens Immunohistochemistry Kidney Neoplasm Male | ||
| 1 (4.0%) |
30374884 |
Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature. Futsukaichi Y, Tajiri K, Kobayashi S, Nagata K, Yasumura S, Takahara T, Minemura M, Yasuda I. Clin J Gastroenterol. 2019;12(2):128-134. |
| Cirrhosis | ||
| Antineoplastic Agents Antiviral Agents Cholangiocarcinoma Hepatitis C, Chronic Homo sapiens Liver Cirrhosis Male Middle Aged Neoplasms, Multiple Primary Protein Kinase Inhibitors Remission Induction | ||
| 1 (4.0%) |
30373546 (6205787) |
Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review. Zhang ZG, Chen Y, Ji R, Zhao YJ, Wang J, Robinson L, Chen XP, Zhang L. BMC Cancer. 2018;18(1):1046. |
| Carcinoma | ||
| Biological Markers Cholangiocarcinoma Combined Modality Therapy Fatal Outcome Females Homo sapiens Immunohistochemistry Magnetic Resonance Imaging Neoplasms, Multiple Primary X-Ray Computed Tomography | ||
| 1 (4.0%) |
29967709 (6008645) |
Two Surgical Cases of Combined Hepatocellular-Cholangiocarcinoma, Intermediate-Cell Subtype: Potentially Characteristic Gross Features. Watanabe J, Yamada S, Sasaguri Y, Inagaki M, Iwagaki H. Case Rep Pathol. 2018;2018:8423939. |
| Carcinoma | ||
| 1 (4.0%) |
29904468 (6000012) |
Rapidly progressing lepidic pulmonary metastases from a treated poorly differentiated hepatocellular carcinoma demonstrating new pathologic features of cholangiocarcinoma: A potential diagnostic pitfall that may mimic pneumonia. Hota P, Dass C, Kumaran M, Zhao X, Jhala N, Simpson S. Radiol Case Rep. 2018;13(2):336-342. |
| Pneumonia | ||
| 1 (4.0%) |
29504997 (5779766) |
Clinicopathological features of combined hepatocellular-cholangiocarcinoma with sarcomatous change: Case report and literature review. Gu Q, Yu X, Chen H, Chen G. Medicine (Baltimore). 2018;97(3):e9640. |
| Cirrhosis | ||
| Adult Bile Duct Neoplasms Cholangiocarcinoma Homo sapiens Male Middle Aged Neoplasms, Multiple Primary | ||
| 1 (4.0%) |
29467557 (5807945) |
Esophageal metastasis of stem cell-subtype hepatocholangiocarcinoma: Rare presentation of a rare tumor. Salimon M, Chapelle N, Matysiak-Budnik T, Mosnier JF, Frampas E, Touchefeu Y. World J Gastroenterol. 2018;24(7):870-875. |
| Dysphagia | ||
| Antineoplastic Combined Chemotherapy Protocols Bile Duct Neoplasms Cholangiocarcinoma Esophageal Neoplasms Fatal Outcome Homo sapiens Liver Liver Cirrhosis Magnetic Resonance Imaging Male Middle Aged Rare Diseases | ||
| 1 (4.0%) |
28806238 |
68Ga-PSMA Uptake in Combined Hepatocellular Cholangiocarcinoma With Skeletal Metastases. Alipour R, Gupta S, Trethewey S. Clin Nucl Med. 2017;42(10):e452-e453. |
| Prostate cancer | ||
| FOLH1 KLK3 | ||
| Bile Duct Neoplasms Biological Transport Cholangiocarcinoma Gallium Isotopes Gallium Radioisotopes Homo sapiens Male Oligopeptides | ||
| 1 (4.0%) |
28629380 (5477246) |
Retinal and vitreous metastases from hepatocholangiocarcinoma. Praidou A, Jacob S, Irion L, Sivaraj R, Groenewald C, Coupland SE, Heimann H. BMC Cancer. 2017;17(1):430. |
| Cataract | ||
| Antineoplastic Combined Chemotherapy Protocols Bile Duct Neoplasms Biopsy Cholangiocarcinoma Fatal Outcome Homo sapiens Immunohistochemistry Male Retinal Neoplasms Vitrectomy X-Ray Computed Tomography |
Total: 0
| HPO ID | Term | Frequency |
|---|
Total: 8
| HPO ID | Term | # of case reports |
|---|---|---|
| HP:0030731 | Carcinoma | 7 |
| HP:0001394 | Cirrhosis | 2 |
| HP:0002664 | Neoplasm | 2 |
| HP:0002835 | Aspiration | 2 |
| HP:0000952 | Jaundice | 1 |
| HP:0001667 | Right ventricular hypertrophy | 1 |
| HP:0002204 | Pulmonary embolism | 1 |
| HP:0003003 | Colon cancer | 1 |
Total: 0
| Gene Symbol | Gene Name | Entrez Gene ID |
|---|